Abstract:The ability to rapidly detect apoptotic cells and accurately evaluate therapeutic effects is significant in cancer research. To address this target, a biocompatible, ultrasensitive photoelectrochemical (PEC) cytosensing platform was developed based on electrochemically reduced graphene (EG)/ZnIn2S4 cosensitized TiO2 coupled with specific recognition between apoptotic cells and phosphatidylserine-binding peptide (PSBP). In this strategy, the HL-60 cells were selected as a model and C005, nilotinib, and imatinib were selected as apoptosis inducers to show cytosensing performances. In particular, a TiO2 photoactive substrate was designed as hollow spheres to enhance the PEC performance. Graphene was electrodeposited on the hollow TiO2-modified electrode to accelerate electron transfer and increase conductivity, followed by in situ growth of ZnIn2S4 nanocrystals as photosensitizers via successive ionic layer adsorption and reaction method, forming a TiO2/EG/ZnIn2S4 cosensitized structure that was used as a PEC matrix to immobilize PSBP for the recognition of early apoptotic cells. The detection of apoptotic cells was based on steric hindrance originating from apoptotic cell capture to induce an obvious decrease in the photocurrent signal. The ultrahigh sensitivity of the cytosensor resulted from enhanced PEC performance, bioactivity, and high binding affinity between PSBP and apoptotic cells. Compared with other assays, incorporate toxic elements were avoided, such as Cd, Ru, and Te, which ensured normal cell growth and are appropriate for cell analysis. The designed PEC cytosensor showed a low detection limit of apoptotic cells (as low as three cells), a wide linear range from 1 × 103 to 5 × 107 cells/mL, and an accurate evaluation of therapeutic effects. It also exhibited good specificity, reproducibility, and stability.

Toward the early evaluation of therapeutic effects: an electrochemical platform for ultrasensitive detection of apoptotic cells.

Ultrasensitive Amperometric Cytosensor for Drug Evaluation with Monitoring Early Cell Apoptosis Based on Cu2O@PtPd Nanocomposite As Signal Amplified Label

An Annexin V-based Biosensor for Quantitatively Detecting Early Apoptotic Cells

Toward Therapeutic Effects Evaluation of Chronic Myeloid Leukemia Drug: Electrochemical Platform for Caspase-3 Activity Sensing.

An electrochemical-TUNEL method for sensitive detection of apoptotic cells.

Nanoarchitectured electrochemical cytosensors for selective detection of leukemia cells and quantitative evaluation of death receptor expression on cell surfaces.

A label-free electrochemiluminescence cytosensors for specific detection of early apoptosis.

Evaluating Early Apoptosis-Related Cellular MiRNAs with an Ultrasensitive Electrochemiluminescence Nanoplatform

Peptide-Based Photoelectrochemical Cytosensor Using a Hollow-TiO2/EG/ZnIn2S4 Cosensitized Structure for Ultrasensitive Detection of Early Apoptotic Cells and Drug Evaluation.

Signal amplification cytosensor for evaluation of drug-induced cancer cell apoptosis.

A Novel Aptamer-Based Competition Strategy for Ultrasensitive Electrochemical Detection of Leukemia Cells.

Aptamer-based Electrochemical Analysis Platform for Tumor Cells and Biomarkers Detection

Electrochemical approach to detect apoptosis.

Smart Plasmonic Nanorobot for Real-Time Monitoring Cytochrome C Release and Cell Acidification in Apoptosis During Electrostimulation

Lab-on-a-Chip for Anticancer Drug Screening Using Quantum Dots Probe Based Apoptosis Assay.

Multiplex acute leukemia cytosensing using multifunctional hybrid electrochemical nanoprobes at a hierarchically nanoarchitectured electrode interface.

Analysis of nonadherent apoptotic cells by a quantum dots probe in a microfluidic device for drug screening.

Competitive Electrochemical Platform for Ultrasensitive Cytosensing of Liver Cancer Cells by Using Nanotetrahedra Structure with Rolling Circle Amplification.

Chronic Myeloid Leukemia Drug Evaluation Using a Multisignal Amplified Photoelectrochemical Sensing Platform

Ultrasensitive Cytosensor Based on Self-enhanced Electrochemiluminescent Ruthenium-Silica Composite Nanoparticles for Efficient Drug Screening with Cell Apoptosis Monitoring.

Microfluidic chip integrated with flexible PDMS-based electrochemical cytosensor for dynamic analysis of drug-induced apoptosis on HeLa cells.